What is Healogics?
Established in 1996 and headquartered in Jacksonville, Florida, Healogics is dedicated to providing specialized treatment for chronic wounds. Their expertise spans a range of complex conditions, including diabetic ulcers, surgical wounds, venous ulcers, pressure ulcers, trauma wounds, and arterial ulcers. The company's focus on advanced wound care positions it as a critical service provider within the healthcare sector, addressing a growing need for effective chronic wound management solutions.
How much funding has Healogics raised?
Healogics has raised a total of $165M across 1 funding round:
Private Equity
$165M
Private Equity (2021): $165M with participation from Marathon Asset Management
Key Investors in Healogics
Marathon Asset Management
Marathon Asset Management, through its affiliate MCAP Global Finance (UK) LLP, is a significant backer in the investment management space. Their involvement suggests a strategic financial partnership aimed at supporting Healogics' growth initiatives and market expansion.
What's next for Healogics?
The recent major strategic investment signals a pivotal moment for Healogics, likely enabling expansion of its service offerings, technological advancements in wound care, and broader market penetration. This significant capital infusion, part of its $165M in total financing, suggests a strategic push towards scaling operations and solidifying its market leadership in the specialized field of advanced wound care. The company is poised for further growth and innovation in addressing complex patient needs.
See full Healogics company page
